Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
about
Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische KopfschmerzgesellschLow migraine headache recurrence with naratriptan: clinical parameters related to recurrenceHow does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.Cardiovascular tolerability and safety of triptans: a review of clinical data.Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine.Naratriptan: an alternative for migraine.Migraine: a comprehensive review of new treatment options.Current and emerging second-generation triptans in acute migraine therapy: a comparative review.Providing relief from headache pain. Current options for acute and prophylactic therapy.Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.The triptan formulations: a critical evaluation.Triptans: are they all the same?Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of lifeNew paradigms in the recognition and acute treatment of migraine.Headache recurrence as a criterion for assessing efficacy of triptans: a perspective.Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans.Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.Naratriptan: a review.Modifiable risk factors for migraine progression.Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a commentAcute migraine in the Emergency Department: extending European principles of management.Perimenstrual migraines: are they different from migraines in general?Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register.Comparative tolerability of treatments for acute migraine: A network meta-analysis.A model-based approach to treatment comparison in acute migraine.Efficacy of oral naratriptan in the treatment of menstrually related migraine.Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan.Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine.Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study.Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States.Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study.Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.Naratriptan May Become an Alternative Prophylactic Option for Patients with Cluster Headache.Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.Differentiating the efficacy of 5-HT(1B/1D) agonists.
P2860
Q24619383-DC78A194-EB4A-4C73-BAC0-DD93608BAB6AQ28376494-4379B59B-F6C4-4C98-8D43-51C4B6EB519FQ30692301-E0EF2B70-1553-4DEA-B51C-225A04786C09Q30932202-19373FBE-CDDE-4196-B720-7D6FA4552D0EQ31119065-69103783-0A2A-4E8C-A72C-14DD58204299Q32039000-52A1C3BA-4718-4A29-84C8-29CAEB8F1A6EQ33689204-12F5C832-1BE3-41B8-81FE-7E67D28C1D11Q33715929-8ADF299D-68B9-4F0E-956F-2F67FF32A738Q33908453-735F685E-5439-4B8F-A384-D5E87D67057AQ34044773-D5247269-AEA4-4F86-B35A-1D25EE71F9BDQ34154647-736C0AA0-CB7A-4B21-B584-553AA4CC8471Q34205890-8B87164C-962B-4B4F-8DE1-D78CA592CC64Q34548441-88CBB175-D90C-4217-A9B5-07D8B2C9B6D8Q34614148-7C02667E-6E27-4B5C-8AD8-D86D45672440Q34634345-4816C42D-7CA8-49D3-B811-4925F389E478Q34634351-1718D41E-D6D9-48C7-81E4-FABD6FE49EBDQ35091964-1E716D54-CD3A-443B-845E-D4D1E635E7C4Q35129772-D23ACE47-77D4-4C68-A36F-A4E979ED2CC6Q35775292-FC44CC7B-F753-4216-934A-808867B642D5Q36181337-1FE79412-F551-4068-9AFB-A02D3428400AQ36623145-11488AA8-ED43-4434-B17D-F5E851B01CDBQ36978875-17820F75-0798-4388-92E1-55D2760D21DFQ37266261-65883F4A-23A8-465A-B7E0-E127412476B3Q37313509-68342992-15FE-4091-A89E-FAB9F394FA7DQ37857762-82B0BE18-F602-4C2B-8321-F0AE079F1037Q38927015-FDECE793-5D7A-472F-AF73-F04E01402CFDQ39344317-CC7CE54D-698A-4EC5-A5AE-0D4F281FA10CQ39361381-DF69A19C-3893-4E5F-B268-A0DF97612C5CQ39361566-91F7F241-7FAF-4F8E-99CC-260989A18912Q39365133-7B470D40-084A-477E-A5B8-C4E3C0C0795BQ39391112-DAED5AED-B215-425F-8ECC-43496CD399E2Q39397606-ED308A32-7F25-4304-80AC-8E4A5E2FB57FQ39404886-D928CEDA-7CE3-41A6-9BFA-09C10FDED374Q39414225-AC0CCEB3-F810-4E69-88DC-4C575A1FE8B6Q39427714-8AA0AC9C-0DCE-4553-92C9-458AD186D5D7Q39439890-54852964-40B6-4337-AF0D-FE3A2CDF7170Q39447979-BDE280F0-1745-47FC-860D-7D91BD1F591BQ42620111-1F5292C3-F05D-475A-B9C1-6DB73938E51FQ43551354-ADB3617F-DF14-4CE7-AC74-5726241E35B3Q43551356-B113F6A4-CFDB-4EC2-AF57-E92B065B5064
P2860
Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@en
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@nl
type
label
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@en
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@nl
prefLabel
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@en
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@nl
P2093
P356
P1433
P1476
Naratriptan is effective and w ...... atriptan S2WA3003 Study Group.
@en
P2093
A Laurenza
M Asgharnejad
M Peykamian
N T Mathew
P304
P356
10.1212/WNL.49.6.1485
P407
P577
1997-12-01T00:00:00Z